MeMed
About
MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes. Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders, at the right place and the right time.
Pricing
View pricing page ↗
Technology stack
detected 2026-06-13Est. monthly stack spend~$1,010/mo
Email
Google Workspace
Hosting
self_managed
Stack
jQuery
WordPress
Analytics
Google Analytics 4
Google Tag Manager
SEO
All in One SEO
Cookie consent
OneTrust
Affiliate
Self-hosted affiliate
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does MeMed do?
MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes. Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders, at the right place and the right time.
How much funding has MeMed raised?
MeMed has raised a total of $196M in funding. The most recent round on record is Series E.
When was MeMed founded?
MeMed was founded in 2009.
What industry does MeMed operate in?
MeMed operates in Healthcare, Blood, Diagnostics.
How many employees does MeMed have?
MeMed has approximately 99 people on record.